Skip to content

An Exploratory Study on the Effects of Tea Consumption on Urinary Sodium Excretion and Blood Pressure

An Exploratory Study on the Effects of Tea Consumption on Urinary Sodium Excretion and Blood Pressure

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125050
Enrollment
Unknown
Registered
2026-05-20
Start date
2022-12-25
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

A Group(Tea Group):Participants will consume Deepuer tea (total theophylline content: 3 g/day), 6 bags daily. Each bag is to be steeped in 250–500 ml of water. Total daily fluid intake from tea: 1500–
B Group(Water Group):Participants will consume purified water, 350 ml per bottle, 4-5 bottles daily. Total daily water intake: 1500~2000 ml.

Sponsors

The Third Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Stage 1 hypertension (140–159/90–99 mmHg) without antihypertensive medication use or after a 2-week washout period. 2. Age 18–80 years. 3. Urinary sodium excretion >=130 mmol/day (spot urine). 4. No history of tea or coffee consumption within the preceding 2 weeks. 5. Provided informed consent and volunteered to participate.

Exclusion criteria

Exclusion criteria: 1. Heart failure or renal failure. 2. Hypertensive patients currently taking antihypertensive medication. 3. Patients with a history of palpitations or insomnia due to consumption of coffee or strong tea. 4. Individuals with psychiatric disorders, or those unable to complete the tea/water consumption process due to personal physiological or health reasons.

Design outcomes

Primary

MeasureTime frame
Blood Pressure;

Secondary

MeasureTime frame
urinary sodium excretion;urinary caffeine excretion;

Countries

China

Contacts

Public ContactNingling Sun/ Hong Yuan

Peking University People's Hospital/The Third Xiangya Hospital of Central South University

sunnl@263.net+86 137 0133 3202

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026